Pfizer’s Covid vaccine and treatment drive second-quarter earnings beat

Pfizer’s Covid vaccine and treatment drive second-quarter earnings beat


Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022.

Jennifer Lorenzini | Reuters

Pfizer’s second-quarter revenue and profit beat Wall Street expectations, driven by sales of its Covid-19 vaccine and its antiviral treatment Paxlovid.

Pfizer’s revenue grew by 47% to $27.7 billion compared the same quarter last year. The pharmaceutical company booked net income of $9.9 billion, a 78% increase over the same period in 2021.

Here’s how the company performed compared with what Wall Street expected for the second quarter, based on analysts’ average estimates compiled by Refinitiv:

  • Adjusted EPS: $2.04 per share, vs $1.78 expected
  • Revenues: $27.7 billion, vs. $25.7 billion

Pfizer’s Covid vaccine brought in $8.8 billion in revenue for the second quarter, while sales of Paxlovid totaled $8.1 billion. The company maintained its 2022 sales guidance for the vaccine of $32 billion and is still expecting $22 billion for Paxlovid.

The company also reiterated its overall 2022 revenue and earnings guidance. Pfizer is expecting $98 billion to $102 billion in sales this year and earnings per share of $6.30 to $6.45.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

CDC Director Susan Monarez ousted, four other leaders quit health agency
Health

CDC Director Susan Monarez ousted, four other leaders quit health agency

Susan Monarez, President Donald Trump’s nominee to be the Director of the Centers for Disease Control and Prevention (CDC), testifies during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions in the Dirksen Senate Office Building on June 25, 2025 in Washington, DC. Kayla Bartkowski | Getty Images Centers for Disease […]

Read More
FDA approves new Covid shots with limits on who can get them, as RFK Jr. changes vaccine precedents
Health

FDA approves new Covid shots with limits on who can get them, as RFK Jr. changes vaccine precedents

Pfizer’s Covid vaccine Comirnaty, seen at a CVS Pharmacy in Eagle Rock, California, Sept. 14, 2023. Irfan Khan | Los Angeles Times | Getty Images The Food and Drug Administration on Wednesday approved the latest round of Covid vaccines in the U.S., but set new limits on who can get them. The agency ended its […]

Read More
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Health

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data

The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Eli Lilly‘s closely watched obesity pill is inching closer […]

Read More